http://feed.informer.com/digests/E3Q2DYR7OV/feeder nutrition_oncologie Respective post owners and feed distributors Thu, 04 Apr 2019 11:22:16 -0400 Feed Informer http://feed.informer.com/ https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156548689&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:d43abb82-825f-31a0-8229-90ad669c6ed4 Wed, 01 Jun 2022 00:00:00 -0400 Supportive Care in Cancer; 06/01/2022<br/>(AN 156548689); ISSN: 09414355<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156835412&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:91edfbe9-6476-d9a9-6e7b-37ff61b98312 Wed, 01 Jun 2022 00:00:00 -0400 Nutrition & Cancer; 06/01/2022<br/>(AN 156835412); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156835428&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:d1e90a99-76a9-43a2-f88b-0df8e33af028 Wed, 01 Jun 2022 00:00:00 -0400 Nutrition & Cancer; 06/01/2022<br/>(AN 156835428); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156835424&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:db2adbd0-a100-e90c-e055-f747320ba2ba Wed, 01 Jun 2022 00:00:00 -0400 Nutrition & Cancer; 06/01/2022<br/>(AN 156835424); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156835438&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:8ef98ae6-36f9-eaf6-dcef-d188bc3e105d Wed, 01 Jun 2022 00:00:00 -0400 Nutrition & Cancer; 06/01/2022<br/>(AN 156835438); ISSN: 01635581<br/>CINAHL Complete http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&MODE=ovid&PAGE=fulltext&NEWS=n&D=emexb&AUTOALERT=293779288%7c1 nutrition_oncology_embase urn:uuid:4bee1910-f590-4e0a-a335-c14f7f065a43 Sat, 21 May 2022 04:18:41 -0400 <div class="field" > <strong>Author Names:</strong> <span>Lang J.,Shao Y.,Liao J.,Chen J.,Zhou X.,Deng R.,Wang W.-J.,Sun X.</span> </div> <div class="field" > <strong>Database Source:</strong> <span>Embase Weekly Updates</span> </div> <div class="field" > <strong>Journal Title:</strong> <span>British Journal of Nutrition,British Journal of Nutrition</span> </div> <div class="field" > <strong>Article Title:</strong> <span><a href="http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;MODE=ovid&amp;PAGE=fulltext&amp;NEWS=n&amp;D=emexb&amp;AUTOALERT=293779288%7c1">Patient-Generated Subjective Global Assessment (PG-SGA) predicts length of hospital stay in lung adenocarcinoma patients</a></span> </div> <div class="field" > <strong>Year:</strong> <span>2022</span> </div> <div class="field" > <strong>Issue:</strong> <span>10</span> </div> <div class="field" > <strong>Volume:</strong> <span>127</span> </div> <div class="field" > <strong>Abstract:</strong> <span>The prevalence of malnutrition is high among oncology patients in Northern China. Malnutrition is related to the longer hospital stay, and it can be used to predict the prognostic outcome of patients. This work focused on investigating the relationship of nutritional condition with the length of hospital stay (LOS) in Northern Chinese patients with lung adenocarcinoma (LUAD). The Patient-Generated Subjective Global Assessment (PG-SGA), Nutritional Risk Screening 2002 (NRS 2002) score, recent weight loss and BMI were assessed in a probabilistic sample of 389 LUAD patients without epidermal growth factor receptor (EGFR) mutations. This study collected the demographic and clinical features of patients in a prospective manner. Then, we examined the association of nutritional status with LOS among the population developing LUAD. According to the PG-SGA, 63 (16.3 %), 174 (44.7 %) and 78 (20.1 %) patients were at risk for undernutrition, moderate undernutrition and severe undernutrition, respectively. Nutritional risk was found in 141 (36.2 %) patients based on the NRS 2002. The average LOS for tumour patients in Northern China was 12.5 d. At admission, a risk of undernutrition or undernutrition according to the PG-SGA (P &lt; 0.001), NRS 2002 (P &lt; 0.001) and latest weight loss (P &lt; 0.001) predicted the longer LOS. LOS was related to nutritional status and hospitalisation expenses (P &lt; 0.001). LUAD patients who stayed in the ICU had a poorer nutritional status and a longer LOS (P &lt; 0.001). In Northern Chinese patients with LUAD, a risk for undernutrition evaluated by the PG-SGA, the NRS 2002 and recent weight loss, but not BMI, could predict a longer LOS. &lt;br/&gt;Copyright &amp;#xa9; The Author(s), 2021. Published by Cambridge University Press on behalf of The Nutrition Society.</span> </div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155913100&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:46b9be2b-1071-4ac9-5dbc-854c2627c5c4 Sun, 01 May 2022 00:00:00 -0400 Supportive Care in Cancer; 05/01/2022<br/>(AN 155913100); ISSN: 09414355<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155913127&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:3a092210-d9f0-7f11-27d9-b0f09af18f44 Sun, 01 May 2022 00:00:00 -0400 Supportive Care in Cancer; 05/01/2022<br/>(AN 155913127); ISSN: 09414355<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155734715&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:1f424354-01ac-32d2-46bf-e59ddbeb4777 Sun, 01 May 2022 00:00:00 -0400 Nutrients; 05/01/2022<br/>(AN 155734715); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156475265&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:9c8a43e8-3040-4570-5b64-bf3955624eb0 Sun, 01 May 2022 00:00:00 -0400 Nutrition & Cancer; 05/01/2022<br/>(AN 156475265); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156475271&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:a827635d-4a20-366c-aad6-944b96efed15 Sun, 01 May 2022 00:00:00 -0400 Nutrition & Cancer; 05/01/2022<br/>(AN 156475271); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156849603&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:84b5c321-2e78-c03b-b46e-e42a2015d52e Sun, 01 May 2022 00:00:00 -0400 Cancers; 05/01/2022<br/>(AN 156849603); ISSN: 20726694<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156849362&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:8b68cc52-cb20-008c-f649-266b978d7447 Sun, 01 May 2022 00:00:00 -0400 Cancers; 05/01/2022<br/>(AN 156849362); ISSN: 20726694<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/35392843/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:3c5febc5-607c-cbd8-772a-8b38e9f9c33c Thu, 07 Apr 2022 20:00:00 -0400 CONCLUSIONS: Higher pre-treatment PNI was associated with better OS, while lower pre-treatment PNI and higher treatment SII were associated with poorer DFS in oral cancer patients. Our data indicated that PNI and SII might offer useful biomarkers for gauging prognosis and the efficacy of conventional therapies. <div><p style="color: #4aa564;">BMC Cancer. 2022 Apr 7;22(1):368. doi: 10.1186/s12885-022-09439-x.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: This study aimed to evaluate the utility of inflammation-based prognostic scores (IBPS) and systemic immune-inflammation index (SII) in the treatment of oral cancer patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: For the 183 patients enrolled in this study, IBPS and SII were calculated from peripheral blood samples obtained before and after treatment and at the time of relapse. We examined overall survival (OS) and disease-free survival (DFS) using previously reported cut-off values for IBPS. Cut-off values of neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and prognostic nutritional index (PNI) were analyzed as NLR 1.79, PLR 114.97, LMR 5, and PNI 52.44. The cut-off value for SII was set at 569. OS and DFS were analyzed by Kaplan-Meier methods using the cutoff of each IBPS and SII. Univariate analysis and multivariate analysis using Cox proportional hazards were performed for OS and DFS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Kaplan-Meier methods showed the high-PNI group showed good prognosis including OS and DFS, while the high-SII group displayed poor DFS. Univariate analysis showed that pre-treatment high PNI and low SII were significantly associated with better prognosis. Multivariate analysis identified pre-treatment PNI as independently associated with OS. For DFS, univariate analysis using Cox proportional hazards modeling showed that pre-treatment high NLR and high SII were significantly associated with worse prognosis, while high PNI was significantly associated with better prognosis. Multivariate analysis identified pre-treatment PNI and SII as independently associated with DFS. Parameters of PNI and SII components were compared between pre-treatment, post-treatment and at relapse in the high- and low-PNI groups. PNI was predominantly decreased in both high- and low-PNI groups at post-treatment and at relapse compared to pre-treatment. This trend was also observed for albumin.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Higher pre-treatment PNI was associated with better OS, while lower pre-treatment PNI and higher treatment SII were associated with poorer DFS in oral cancer patients. Our data indicated that PNI and SII might offer useful biomarkers for gauging prognosis and the efficacy of conventional therapies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35392843/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35392843</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8991673/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">PMC8991673</a> | DOI:<a href=https://doi.org/10.1186/s12885-022-09439-x>10.1186/s12885-022-09439-x</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156190885&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:bb33e78d-0c8a-ce5d-afe5-6ff24a16dcba Thu, 07 Apr 2022 00:00:00 -0400 BMC Cancer; 04/07/2022<br/>(AN 156190885); ISSN: 14712407<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155521209&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:8c73862a-ef6e-4a66-c568-4f1ed8ccf11d Fri, 01 Apr 2022 00:00:00 -0400 Nutrients; 04/01/2022<br/>(AN 155521209); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155761769&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:6bd3d6e2-07b7-8398-7aab-e4fc8ed2600e Fri, 01 Apr 2022 00:00:00 -0400 Nutrition Reviews; 04/01/2022<br/>(AN 155761769); ISSN: 00296643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155930077&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:285f1452-6be6-084d-7582-582a0d446848 Fri, 01 Apr 2022 00:00:00 -0400 Nutrition & Cancer; 04/01/2022<br/>(AN 155930077); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155930083&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:810be092-514a-056a-a7ea-f3107cba778f Fri, 01 Apr 2022 00:00:00 -0400 Nutrition & Cancer; 04/01/2022<br/>(AN 155930083); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155930094&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:fa4acb05-9483-8143-40de-31ea1459f7e0 Fri, 01 Apr 2022 00:00:00 -0400 Nutrition & Cancer; 04/01/2022<br/>(AN 155930094); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156194794&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:394eb392-ee51-5916-97d8-c0d5ccba70dc Fri, 01 Apr 2022 00:00:00 -0400 Nutrition & Dietetics; 04/01/2022<br/>(AN 156194794); ISSN: 14466368<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156555029&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:a4cfae6e-9213-8010-5181-e9c4bfc40a4d Fri, 01 Apr 2022 00:00:00 -0400 Journal of the Advanced Practitioner in Oncology; 04/01/2022<br/>(AN 156555029); ISSN: 21500878<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/35299195/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:7ff3cf15-3b70-fc54-f79f-e4abef05ca0a Wed, 16 Mar 2022 20:00:00 -0400 CONCLUSION: Even in elderly patients with colorectal cancer, preoperative suppression of inflammatory conditions and improvement of nutritional status may contribute to the improvement of long-term prognosis, so mGPS evaluation is useful. <div><p style="color: #4aa564;">Gan To Kagaku Ryoho. 2022 Mar;49(3):327-329.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: In cancer treatment of the elderly, it is important to grasp the"degree of inflammation"and"nutritional status"in advance.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: This study aims to investigate the usefulness of preoperative modified Glasgow Prognostic score(mGPS)evaluation in elderly patients with colorectal cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENT: 89 cases of primary resection of colorectal cancer over 80 years old were enrolled.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In the preoperative mGPS score normal group(score 0)and abnormal group (scores 1 or 2)were divided. Clinicopathological factors(patient-related 13 factors, treatment-related 6 factors, and tumor-related 4 factors)were compared, and the long-term results were also investigated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Between 42 cases in the normal group and 47 cases in the abnormal group, there were significant differences(p&lt;0.05)in 6 factors: BMI, total protein, cholinesterase, neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and Onodera prognostic nutritional index. The long-term results(5-year survival rate)were also significantly different in the normal group(76.8%)and the abnormal group(51.6%)(p=0.007).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Even in elderly patients with colorectal cancer, preoperative suppression of inflammatory conditions and improvement of nutritional status may contribute to the improvement of long-term prognosis, so mGPS evaluation is useful.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35299195/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35299195</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156072204&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:f49989ee-d574-d920-2a12-5c4a52144b71 Tue, 15 Mar 2022 00:00:00 -0400 Nutrients; 03/15/2022<br/>(AN 156072204); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156072323&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:7c3d6d27-9f08-72dc-43b3-1e85fb07d24b Tue, 15 Mar 2022 00:00:00 -0400 Nutrients; 03/15/2022<br/>(AN 156072323); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156072353&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:3f4c80aa-e410-75b8-11df-a24413c5e525 Tue, 15 Mar 2022 00:00:00 -0400 Nutrients; 03/15/2022<br/>(AN 156072353); ISSN: 20726643<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155923995&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:f8056fc7-6a20-8058-717e-70fa6055bd01 Thu, 10 Mar 2022 00:00:00 -0500 Chinese General Practice Nursing; 03/10/2022<br/>(AN 155923995); ISSN: 16744748<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/35256659/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:d3e45d91-facd-f842-8ece-9dab890f00e4 Mon, 07 Mar 2022 19:00:00 -0500 The world is becoming longer-lived, and the number of elderly colorectal cancer patients is increasing. It is very important to identify simple and inexpensive postoperative predictors in elderly colorectal cancer patients. The geriatric nutritional risk index (GNRI) is a marker of systemic nutrition and is associated with poor survival in various kinds of cancers. A few reports have investigated recurrence factors using preoperative GNRI with CRC (colorectal cancer) patients. This study aimed... <div><p style="color: #4aa564;">Sci Rep. 2022 Mar 7;12(1):3682. doi: 10.1038/s41598-022-07540-6.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The world is becoming longer-lived, and the number of elderly colorectal cancer patients is increasing. It is very important to identify simple and inexpensive postoperative predictors in elderly colorectal cancer patients. The geriatric nutritional risk index (GNRI) is a marker of systemic nutrition and is associated with poor survival in various kinds of cancers. A few reports have investigated recurrence factors using preoperative GNRI with CRC (colorectal cancer) patients. This study aimed to investigate whether preoperative GNRI is associated with recurrence-free survival (RFS) and overall survival (OS) in elderly patients with CRC. This study retrospectively enrolled 259 patients with Stage I-III CRC who were more than 65 years old and underwent curative surgery at a single institution in 2012-2017. We classified them into low GNRI (RFS: ≤ 90.5, OS ≤ 101.1) group and high GNRI (RFS: &gt; 90.5, OS &gt; 101.1) group. Multivariable analyses showed low GNRI group was an independent risk factor for 3-year RFS (P = 0.006) and OS (P = 0.001) in the patients with CRC. Kaplan-Meier analysis showed 3-year RFS and 3-year OS were significantly worse in the low GNRI group than in high GNRI group (p = 0.001, 0.0037). A low-preoperative GNRI was significantly associated with a poor prognosis in elderly CRC patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35256659/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35256659</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8901671/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">PMC8901671</a> | DOI:<a href=https://doi.org/10.1038/s41598-022-07540-6>10.1038/s41598-022-07540-6</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155324420&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:672c1f8b-95d9-5721-903a-fde4b1968043 Tue, 01 Mar 2022 00:00:00 -0500 Oral Diseases; 03/01/2022<br/>(AN 155324420); ISSN: 1354523X<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155510811&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:3a8a9b04-3747-6d3b-bda0-72411263ff2d Tue, 01 Mar 2022 00:00:00 -0500 Oncology Nursing Forum; 03/01/2022<br/>(AN 155510811); ISSN: 0190535X<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155490022&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:a7dc7aa7-a6ad-b9ca-b24e-243331a565bd Tue, 01 Mar 2022 00:00:00 -0500 Clinical Nutrition; 03/01/2022<br/>(AN 155490022); ISSN: 02615614<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155656423&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:f7ea771c-0428-5b60-b9c5-67c61a645870 Tue, 01 Mar 2022 00:00:00 -0500 JPEN Journal of Parenteral & Enteral Nutrition; 03/01/2022<br/>(AN 155656423); ISSN: 01486071<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/35225460/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:48b2820f-f9e3-cb55-746f-496467fdec26 Sun, 27 Feb 2022 19:00:00 -0500 OBJECTIVE: Gastrointestinal (GI) cancer patients often experience severe malnutrition during cancer therapies due to gastrointestinal dysfunctions including poor digestion and absorption as well as tumor-associated anorexia. In this study, we performed a randomized clinical trial to determine the efficacy of oral nutrition supplement (ONS) enriched with omega-3 fatty acids on nutritional status, quality of life (QOL), and pro-inflammatory indices. <div><p style="color: #4aa564;">Asian Pac J Cancer Prev. 2022 Feb 1;23(2):485-494. doi: 10.31557/APJCP.2022.23.2.485.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: Gastrointestinal (GI) cancer patients often experience severe malnutrition during cancer therapies due to gastrointestinal dysfunctions including poor digestion and absorption as well as tumor-associated anorexia. In this study, we performed a randomized clinical trial to determine the efficacy of oral nutrition supplement (ONS) enriched with omega-3 fatty acids on nutritional status, quality of life (QOL), and pro-inflammatory indices.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients diagnosed with GI cancers were recruited and screened for eligibility. A total of 58 patients were randomly allocated to either the control group (n=27) or the experimental group (n=31). The intervention group received 200 ml ONS twice a day while the control group received routine care. Anthropometrics, Patient-Generated Subjective Global Assessment (PG-SGA) score, QOL score and nutrient intake data were collected at baseline, week 4 and week 8. Blood was drawn for biochemical assessments. Nine patients from each group dropped out of the study Forty patients (18 control patients and 22 intervention patients) completed the study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: This study showed that ONS intervention improved PG-SGA scores in the intervention group (p&lt;0.01). Scores of physical functioning score and role functioning were declined only in the control group and the difference between week 8 and baseline for role functioning was significant (p&lt;0.001). Fatigue score was steadily decreased in the experiment group, and the differences between week 8 and baseline was significant between two groups (p&lt;0.02). However, no statistically significant improvement in biochemical markers of nutritional status and pro-inflammatory cytokine concentrations were found. These results suggests that ONS intervention for 8 weeks improves PG-SGA scores and QOL scores in patients undergoing cancer therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35225460/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35225460</a> | DOI:<a href=https://doi.org/10.31557/APJCP.2022.23.2.485>10.31557/APJCP.2022.23.2.485</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155286369&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:17ce029a-24b9-a948-696a-7d9a9134462e Wed, 02 Feb 2022 00:00:00 -0500 Physiotherapy; 02/02/2022<br/>(AN 155286369); ISSN: 00319406<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/35108317/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:12dbd15b-64c5-bd27-4ebe-e4f4846672a9 Tue, 01 Feb 2022 19:00:00 -0500 CONCLUSION: GNRI is an effective and reliable tool for evaluation of preoperative nutritional status of prostate cancer patients. The findings showed that GNRI is correlated with postoperative recovery and complications, and is an effective predictive marker. <div><p style="color: #4aa564;">PLoS One. 2022 Feb 2;17(2):e0262630. doi: 10.1371/journal.pone.0262630. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND OBJECTIVE: Prostate cancer (PCa) is one of the most common malignant tumors in men. Geriatric Nutritional Risk Index (GNRI) is an objective index for evaluating nutritional status of elderly people over 65 years old. The aim of the current study was to explore the correlation and predictive value between GNRI and postoperative recovery and complications in PCa patients undergoing laparoscopic radical prostatectomy (LRP).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Taking 98 as the GNRI boundary value, 96 PCa patients (aged≥65 y) undergoing LRP in the Department of Urology, Affiliated Hospital of North Sichuan Medical College from January 2018 to December 2020 were grouped into malnutrition group (MNg, 34 patients, 35.4%) and normal nutrition group (NNg, 62 patients, 64.6%). Basic information, laboratory examination indexes, operation conditions, postoperative complications and postoperative recovery indexes of patients were recorded and retrospectively analyzed. Clavien-Dindo Classification System (CDCS) was used to assess postoperative complications. T-test was used to analyze differences between the two groups. ROC curve was generated to determine the predictive value of GNRI for postoperative complications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Percentage of complications was significantly higher in MNg group compared with that in NNg group (P &lt; 0.01). The average grade based on CDCS was significantly lower in NNg group compared with that in MNg group (P &lt; 0.01). Body weight, Body Mass Index (BMI), preoperative hemoglobin value (HGB), serum albumin (ALB) values of MNg and NNg were significantly positively correlated with GNRI (P&lt;0.01). Incidence and severity of postoperative complications of MNg patients were significantly higher compared with those of NNg patients (P&lt;0.05). Average hospitalization cost of MNg patients was higher in MNg patients compared with that of NNg patients (P&lt;0.05). Duration of post-anesthesia care unit (PACU), duration of antibiotic use and duration of indwelling drainage tube were longer in MNg patients compared with those in NNg patients (P&lt;0.05). Furthermore, volume of indwelling drainage tube was higher in MNg patients compared with that in NNg patients (P&lt;0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: GNRI is an effective and reliable tool for evaluation of preoperative nutritional status of prostate cancer patients. The findings showed that GNRI is correlated with postoperative recovery and complications, and is an effective predictive marker.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35108317/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35108317</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8809613/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">PMC8809613</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0262630>10.1371/journal.pone.0262630</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154961282&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:a152b618-1ee3-6f64-36b5-e14ff45359ad Tue, 01 Feb 2022 00:00:00 -0500 Nutrition in Clinical Practice; 02/01/2022<br/>(AN 154961282); ISSN: 08845336<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155310723&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:ba8e54a9-e00a-d21e-42ce-736ae2fce4f3 Tue, 01 Feb 2022 00:00:00 -0500 European Journal of Oncology Nursing; 02/01/2022<br/>(AN 155310723); ISSN: 14623889<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155436642&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:5fd8992b-76af-b45d-9827-6fd2132486bb Tue, 01 Feb 2022 00:00:00 -0500 Nutrition & Cancer; 02/01/2022<br/>(AN 155436642); ISSN: 01635581<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155537626&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:5f57a2cf-98ca-3023-7d78-c1bdfee1502a Tue, 01 Feb 2022 00:00:00 -0500 Chinese Nursing Research; 02/01/2022<br/>(AN 155537626); ISSN: 10096493<br/>CINAHL Complete https://pubmed.ncbi.nlm.nih.gov/35063196/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:d6a920f4-4453-21c1-128d-dcebccffa871 Fri, 21 Jan 2022 19:00:00 -0500 CONCLUSIONS: Nutritional side effects are common in patients treated with immunotherapy. Generally, treatment with a combination of two types of immunotherapy is associated with an increased incidence of nutritional side effects. These side effects last longer and patients lose more weight compared to those receiving one type of immunotherapy. <div><p style="color: #4aa564;">Clin Nutr ESPEN. 2022 Feb;47:163-169. doi: 10.1016/j.clnesp.2021.12.024. Epub 2021 Dec 31.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Recently, there has been an increase in the number of patients treated with immunotherapy. However, the number of studies investigating combination immunotherapies is still limited, resulting in a gap of knowledge regarding the incidence of nutritional side effects, differences in the durations of these side effects, and differences in weight loss between patients undergoing single and combination immunotherapies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this historical cohort study, which was performed from 2017 to 2019, a total of 50 patients who received one type and 50 patients who received two types of immunotherapy were randomly selected, resulting in a sample of 100 patients. The primary objectives were to assess (a) the incidence of nutritional side effects, (b) the differences in the durations of these side effects, and (c) the differences in weight loss between the two groups. The secondary objectives were to assess the time to the first side effect, the time to the first unplanned hospital admission, unplanned hospital admissions, consultations from a dietitian, and nutritional interventions. Data were collected from the electronic patient record. Differences between groups were explored using the two-sample t-test, Mann-Whitney U test, Fisher exact test, or Wilcoxon rank sum test, depending on the type of data and the test assumptions. The time to the first side effect and the time to the first unplanned hospital admission are presented as Kaplan-Meier curves, and differences were calculated using a Cox proportional hazards model.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Patients undergoing a combination of two types of immunotherapy were found to have side effects for statistically significantly longer durations than patients receiving one type of immunotherapy (20 days versus 10 days, p = 0.045). Moreover, patients undergoing a combination of two types of immunotherapy were found to lose more weight (6.2 kg versus 1.2 kg, p &lt; 0.001). At least one side effect was reported in 86% of the patients in the one-therapy group and in 90% of the patients in the combination-therapy group. Furthermore, a high incidence of decreased appetite (70% and 86%), nausea (52% and 68%), vomiting (22% and 46%), and diarrhea/colitis (56% and 54%) was found in both groups. However, the time to the first side effect and the time to the first hospital admission were not statistically significantly different between the one-therapy and combination-therapy groups. Of the total cohort, 26% were admitted unexpectedly during the immunotherapy because they developed immunotherapy-related side effects, whereas 38% of the patients in our sample consulted a dietitian.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Nutritional side effects are common in patients treated with immunotherapy. Generally, treatment with a combination of two types of immunotherapy is associated with an increased incidence of nutritional side effects. These side effects last longer and patients lose more weight compared to those receiving one type of immunotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35063196/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35063196</a> | DOI:<a href=https://doi.org/10.1016/j.clnesp.2021.12.024>10.1016/j.clnesp.2021.12.024</a></p></div> https://pubmed.ncbi.nlm.nih.gov/35011097/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:910f4afe-f344-d399-b2fb-b450cd9adc5d Mon, 10 Jan 2022 19:00:00 -0500 Sufficient postoperative dietary intake is crucial for ensuring a better surgical outcome. This study aimed to investigate the postoperative dietary intake achievement and predictors of postoperative dietary intake among gynecologic cancer patients. A total of 118 participants were included in this secondary analysis. Postoperative dietary data was pooled and re-classified into early postoperative dietary intake achievement (EDIA) (daily energy intake (DEI) ≥ 75% from the estimated energy... <div><p style="color: #4aa564;">Nutrients. 2022 Jan 5;14(1):222. doi: 10.3390/nu14010222.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Sufficient postoperative dietary intake is crucial for ensuring a better surgical outcome. This study aimed to investigate the postoperative dietary intake achievement and predictors of postoperative dietary intake among gynecologic cancer patients. A total of 118 participants were included in this secondary analysis. Postoperative dietary data was pooled and re-classified into early postoperative dietary intake achievement (EDIA) (daily energy intake (DEI) ≥ 75% from the estimated energy requirement (EER)) and delay dietary intake achievement (DDIA) (DEI &lt; 75% EER) There was a significant difference in postoperative changes in weight (<i>p</i> = 0.002), muscle mass (<i>p</i> = 0.018), and handgrip strength (<i>p</i> = 0.010) between the groups. Postoperative daily energy and protein intake in the EDIA was significantly greater than DDIA from operation day to discharged (<i>p</i> = 0.000 and <i>p</i> = 0.036). Four significant independent postoperative dietary intake predictors were found: preoperative whey protein-infused carbohydrate loading (<i>p</i> = 0.000), postoperative nausea vomiting (<i>p</i> = 0.001), age (<i>p</i> = 0.010), and time to tolerate clear fluid (<i>p</i> = 0.016). The multilinear regression model significantly predicted postoperative dietary intake, F (4, 116) = 68.013, <i>p</i> = 0.000, adj. R² = 0.698. With the four predictors' recognition, the integration of a more specific and comprehensive dietitian-led supportive care with individualized nutrition intervention ought to be considered to promote functional recovery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35011097/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">35011097</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8747030/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">PMC8747030</a> | DOI:<a href=https://doi.org/10.3390/nu14010222>10.3390/nu14010222</a></p></div> https://pubmed.ncbi.nlm.nih.gov/34991505/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((("Medical Oncology... urn:uuid:642d370c-7981-834e-ebe8-1ab787729165 Thu, 06 Jan 2022 19:00:00 -0500 CONCLUSIONS: The NUTRISCORE had an extremely low sensitivity in cancer patients in China compared with the MST when the PG-SGA was used as a reference. <div><p style="color: #4aa564;">BMC Cancer. 2022 Jan 6;22(1):43. doi: 10.1186/s12885-021-09135-2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Malnutrition is common in cancer patients. The NUTRISCORE is a newly developed cancer-specific nutritional screening tool and was validated by comparison with the Patient-Generated Subjective Global Assessment (PG-SGA) and Malnutrition Screening Tool (MST) in Spain. We aimed to evaluate the performance of the NUTRISCORE, MST, and PG-SGA in estimating the risk of malnutrition in Chinese cancer patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Data from an open parallel and multicenter cross-sectional study in 29 clinical teaching hospitals in 14 Chinese cities were used. Cancer patients were assessed for malnutrition using the PG-SGA, NUTRISCORE, and MST. The sensitivity, specificity, and areas under the receiver operating characteristic curve were estimated for the NUTRISCORE and MST using the PG-SGA as a reference.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 1000 cancer patients were included. The mean age was 55.9 (19 to 92 years), and 47.5% were male. Of these patients, 450 (45.0%) had PG-SGA B and C, 29 (2.9%) had a NUTRISCORE ≥5, and 367 (36.7%) had an MST ≥ 2. Using the PG-SGA as a reference, the sensitivity, specificity, and area under the curve values of the NUTRISCORE were found to be 6.2, 99.8%, and 0.53, respectively. The sensitivity, specificity, and area under the curve values of the MST were 50.9, 74.9%, and 0.63, respectively. The kappa index between the NUTRISCORE and PG-SGA was 0.066, and that between the MST and PG-SGA was 0.262 (P &lt; 0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The NUTRISCORE had an extremely low sensitivity in cancer patients in China compared with the MST when the PG-SGA was used as a reference.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34991505/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">34991505</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8740059/?utm_source=Firefox&utm_medium=rss&utm_content=1VKH04FWGXvoku36RbGJ_8GNBWj9y0OnS41FNaQUutsveJjEGx&ff=20220517213234&v=2.17.6">PMC8740059</a> | DOI:<a href=https://doi.org/10.1186/s12885-021-09135-2>10.1186/s12885-021-09135-2</a></p></div> https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154533289&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:eebc380c-48c1-b58e-3ce5-70993c2e2432 Thu, 06 Jan 2022 00:00:00 -0500 BMC Cancer; 01/06/2022<br/>(AN 154533289); ISSN: 14712407<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154010527&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:d6b7feac-9cca-bb8f-f1b0-e12eb89a81bc Sat, 01 Jan 2022 00:00:00 -0500 American Journal of Emergency Medicine; 01/01/2022<br/>(AN 154010527); ISSN: 07356757<br/>CINAHL Complete https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155345601&site=ehost-live S4 AND S7 on 2019-04-04 11:19 AM urn:uuid:94a53e4f-e57a-d8d3-cb0c-e225aa076d6f Sat, 01 Jan 2022 00:00:00 -0500 Nutrition & Cancer; 01/01/2022<br/>(AN 155345601); ISSN: 01635581<br/>CINAHL Complete